Several studies have confirmed that ARHGEF11 affects the metabolism of glucose and fatty acids through the insulin signaling pathway and acts as a key determinant of metabolism- and obesity-associated pathologies [16–18]. The gene discussed is ARHGEF11; the disease is obesity due to melanocortin 4 receptor deficiency.